Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf3
|
ENSMUSG00000003051.7 | E74-like factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_135256395_135256604 | Elf3 | 1150 | 0.349236 | 0.59 | 2.0e-06 | Click! |
chr1_135258156_135258342 | Elf3 | 189 | 0.906357 | 0.55 | 1.2e-05 | Click! |
chr1_135261026_135261195 | Elf3 | 2542 | 0.172851 | 0.54 | 1.9e-05 | Click! |
chr1_135261328_135261489 | Elf3 | 2840 | 0.160893 | 0.52 | 4.0e-05 | Click! |
chr1_135256236_135256387 | Elf3 | 1338 | 0.300682 | 0.50 | 1.2e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 24.73 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr5_139388247_139388459 | 10.08 |
Gpr146 |
G protein-coupled receptor 146 |
1432 |
0.28 |
chr8_70609185_70610414 | 10.08 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr9_66181229_66181417 | 9.74 |
Dapk2 |
death-associated protein kinase 2 |
23088 |
0.17 |
chr2_26578486_26578697 | 9.40 |
Egfl7 |
EGF-like domain 7 |
1423 |
0.23 |
chr8_122329580_122330425 | 9.35 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr10_120686221_120686404 | 9.11 |
4930471E19Rik |
RIKEN cDNA 4930471E19 gene |
12891 |
0.15 |
chr2_26139656_26141133 | 9.04 |
Tmem250-ps |
transmembrane protein 250, pseudogene |
127 |
0.93 |
chr14_14354416_14355184 | 8.66 |
Il3ra |
interleukin 3 receptor, alpha chain |
5179 |
0.12 |
chr8_85379651_85379829 | 8.44 |
Mylk3 |
myosin light chain kinase 3 |
1238 |
0.37 |
chr16_11008637_11008970 | 8.15 |
Gm24961 |
predicted gene, 24961 |
14417 |
0.1 |
chr7_111713972_111714123 | 8.06 |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
65930 |
0.12 |
chr9_71606817_71607016 | 8.01 |
Gm6018 |
predicted gene 6018 |
6776 |
0.19 |
chr4_116491325_116491507 | 7.69 |
Ipp |
IAP promoted placental gene |
16133 |
0.13 |
chr9_69442848_69443037 | 7.59 |
Gm18587 |
predicted gene, 18587 |
2021 |
0.2 |
chr12_103956494_103956864 | 7.39 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
219 |
0.88 |
chrX_123721926_123722462 | 7.22 |
Rps12-ps23 |
ribosomal protein S12, pseudogene 23 |
13617 |
0.18 |
chrX_123943434_123943951 | 7.19 |
Rps12-ps20 |
ribosomal protein S12, pseudogene 20 |
13582 |
0.23 |
chr18_61665433_61665940 | 7.09 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
149 |
0.92 |
chr5_137671429_137671814 | 7.04 |
Agfg2 |
ArfGAP with FG repeats 2 |
7305 |
0.08 |
chrX_123271195_123271712 | 7.03 |
Rps12-ps21 |
ribosomal protein S12, pseudogene 22 |
13591 |
0.15 |
chrX_123500550_123501093 | 6.92 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr5_137376317_137376507 | 6.85 |
Zan |
zonadhesin |
25326 |
0.08 |
chr4_154186294_154186445 | 6.83 |
Megf6 |
multiple EGF-like-domains 6 |
15639 |
0.12 |
chr1_36919717_36920078 | 6.83 |
Gm38115 |
predicted gene, 38115 |
3358 |
0.17 |
chr16_91363506_91363795 | 6.81 |
Ifnar2 |
interferon (alpha and beta) receptor 2 |
9133 |
0.12 |
chr8_126829447_126829889 | 6.79 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
9565 |
0.21 |
chr8_124652539_124652931 | 6.78 |
2310022B05Rik |
RIKEN cDNA 2310022B05 gene |
10634 |
0.15 |
chr13_48731402_48731767 | 6.72 |
Rpl17-ps6 |
ribosomal protein L17, pseudogene 6 |
31997 |
0.16 |
chr10_116884549_116884846 | 6.64 |
Myrfl |
myelin regulatory factor-like |
12222 |
0.16 |
chr11_61653094_61653390 | 6.64 |
Grap |
GRB2-related adaptor protein |
23 |
0.98 |
chr13_106836259_106836440 | 6.63 |
Ipo11 |
importin 11 |
28 |
0.5 |
chr15_102393639_102394041 | 6.62 |
Sp1 |
trans-acting transcription factor 1 |
12303 |
0.09 |
chr17_25083410_25083921 | 6.50 |
Tmem204 |
transmembrane protein 204 |
74 |
0.95 |
chr13_60897419_60897689 | 6.45 |
Ctla2b |
cytotoxic T lymphocyte-associated protein 2 beta |
107 |
0.87 |
chr3_115768720_115769146 | 6.45 |
Gm9889 |
predicted gene 9889 |
53783 |
0.11 |
chr18_69782179_69782395 | 6.44 |
Tcf4 |
transcription factor 4 |
99907 |
0.07 |
chrX_53052410_53053563 | 6.43 |
Gm28730 |
predicted gene 28730 |
173 |
0.64 |
chr11_115219393_115219586 | 6.43 |
Nat9 |
N-acetyltransferase 9 (GCN5-related, putative) |
31630 |
0.08 |
chr17_84136736_84137446 | 6.38 |
Gm19696 |
predicted gene, 19696 |
137 |
0.96 |
chr7_28945614_28946203 | 6.33 |
Gm44699 |
predicted gene 44699 |
2380 |
0.16 |
chr7_25477037_25477380 | 6.29 |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
326 |
0.82 |
chr4_137478244_137478657 | 6.28 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
9647 |
0.14 |
chr4_43613178_43613348 | 6.27 |
Gm25262 |
predicted gene, 25262 |
18162 |
0.06 |
chr7_16405093_16405902 | 6.25 |
Gm45508 |
predicted gene 45508 |
1235 |
0.27 |
chr10_54117865_54118073 | 6.22 |
Man1a |
mannosidase 1, alpha |
41360 |
0.14 |
chr5_115977292_115977636 | 6.21 |
Cit |
citron |
9439 |
0.15 |
chr4_8206972_8207146 | 6.21 |
Gm25355 |
predicted gene, 25355 |
28523 |
0.17 |
chr5_111836465_111837021 | 6.14 |
Gm36535 |
predicted gene, 36535 |
43356 |
0.15 |
chr18_32542304_32542816 | 6.12 |
Gypc |
glycophorin C |
7142 |
0.21 |
chr9_107975396_107975585 | 6.07 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
15 |
0.92 |
chr9_123206683_123206834 | 6.07 |
Cdcp1 |
CUB domain containing protein 1 |
9241 |
0.15 |
chr17_26514334_26514507 | 6.06 |
Dusp1 |
dual specificity phosphatase 1 |
5901 |
0.11 |
chr6_91972143_91972459 | 6.05 |
Fgd5 |
FYVE, RhoGEF and PH domain containing 5 |
6577 |
0.15 |
chr4_144404795_144404974 | 5.97 |
Pramef12os |
PRAME family member 12, opposite strand |
16 |
0.96 |
chr7_31002848_31003006 | 5.96 |
Fam187b |
family with sequence similarity 187, member B |
21057 |
0.07 |
chr11_70230183_70230770 | 5.90 |
Bcl6b |
B cell CLL/lymphoma 6, member B |
678 |
0.4 |
chr7_45708987_45709454 | 5.88 |
Dbp |
D site albumin promoter binding protein |
1331 |
0.17 |
chr7_25433013_25433608 | 5.84 |
Gm15495 |
predicted gene 15495 |
10153 |
0.09 |
chr11_106382523_106382839 | 5.82 |
Icam2 |
intercellular adhesion molecule 2 |
100 |
0.95 |
chr12_76552746_76552916 | 5.81 |
AI463170 |
expressed sequence AI463170 |
4888 |
0.15 |
chr10_80075329_80075620 | 5.81 |
Sbno2 |
strawberry notch 2 |
35 |
0.95 |
chr3_103802171_103802495 | 5.77 |
Gm15471 |
predicted gene 15471 |
796 |
0.38 |
chr13_37666246_37666836 | 5.74 |
AI463229 |
expressed sequence AI463229 |
1 |
0.96 |
chr8_10924334_10925220 | 5.72 |
3930402G23Rik |
RIKEN cDNA 3930402G23 gene |
3667 |
0.12 |
chr7_35386646_35386984 | 5.71 |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
4250 |
0.15 |
chr14_76582580_76582731 | 5.70 |
Serp2 |
stress-associated endoplasmic reticulum protein family member 2 |
25766 |
0.17 |
chr10_76636101_76636288 | 5.70 |
Col6a2 |
collagen, type VI, alpha 2 |
12564 |
0.14 |
chr9_50746476_50746671 | 5.67 |
2310030G06Rik |
RIKEN cDNA 2310030G06 gene |
37 |
0.95 |
chr11_61366580_61366948 | 5.67 |
Slc47a1 |
solute carrier family 47, member 1 |
1112 |
0.41 |
chr3_96953842_96954267 | 5.63 |
Gja8 |
gap junction protein, alpha 8 |
28034 |
0.12 |
chr11_105125823_105126961 | 5.61 |
Mettl2 |
methyltransferase like 2 |
33 |
0.97 |
chr11_16977011_16977361 | 5.59 |
Fbxo48 |
F-box protein 48 |
25776 |
0.13 |
chr2_155553173_155553341 | 5.59 |
Acss2os |
acyl-CoA synthetase short-chain family member 2, opposite strand |
3673 |
0.1 |
chr11_86587246_86587688 | 5.54 |
Vmp1 |
vacuole membrane protein 1 |
473 |
0.75 |
chr1_74027469_74027800 | 5.54 |
Tns1 |
tensin 1 |
9499 |
0.23 |
chr10_4079344_4079540 | 5.51 |
Gm25515 |
predicted gene, 25515 |
24871 |
0.17 |
chr4_150798850_150799180 | 5.49 |
Gm13049 |
predicted gene 13049 |
26718 |
0.15 |
chr11_116506385_116506879 | 5.45 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr9_116174734_116175673 | 5.45 |
Tgfbr2 |
transforming growth factor, beta receptor II |
62 |
0.97 |
chr7_128320559_128320729 | 5.40 |
Gm6916 |
predicted pseudogene 6916 |
5860 |
0.11 |
chr12_80230101_80230731 | 5.40 |
Gm47767 |
predicted gene, 47767 |
21173 |
0.13 |
chr5_32594494_32594645 | 5.32 |
Yes1 |
YES proto-oncogene 1, Src family tyrosine kinase |
16602 |
0.11 |
chr14_21032131_21032511 | 5.29 |
Vcl |
vinculin |
10318 |
0.18 |
chr8_83332377_83333157 | 5.28 |
Elmod2 |
ELMO/CED-12 domain containing 2 |
281 |
0.87 |
chrX_36129493_36129644 | 5.24 |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
17458 |
0.19 |
chr17_26793496_26793647 | 5.24 |
Bnip1 |
BCL2/adenovirus E1B interacting protein 1 |
2796 |
0.2 |
chr8_114882578_114882764 | 5.20 |
Gm22556 |
predicted gene, 22556 |
170242 |
0.03 |
chr9_58232484_58232635 | 5.13 |
Pml |
promyelocytic leukemia |
826 |
0.47 |
chr8_83799666_83799817 | 5.12 |
Gm45778 |
predicted gene 45778 |
50237 |
0.08 |
chr6_48700249_48700426 | 5.12 |
Gimap6 |
GTPase, IMAP family member 6 |
5899 |
0.08 |
chr1_85093943_85094453 | 5.12 |
Gm10553 |
predicted gene 10553 |
5314 |
0.1 |
chr8_27107416_27107607 | 5.10 |
Adgra2 |
adhesion G protein-coupled receptor A2 |
6622 |
0.12 |
chr15_80989871_80990022 | 5.10 |
Sgsm3 |
small G protein signaling modulator 3 |
11889 |
0.12 |
chr8_119425697_119426071 | 5.08 |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
8240 |
0.15 |
chr6_90678769_90679044 | 5.06 |
Gm24816 |
predicted gene, 24816 |
2614 |
0.21 |
chr9_107975677_107975903 | 5.05 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
135 |
0.86 |
chr3_129881265_129881644 | 5.04 |
Pla2g12a |
phospholipase A2, group XIIA |
270 |
0.89 |
chr2_164437602_164437989 | 5.03 |
Sdc4 |
syndecan 4 |
5391 |
0.09 |
chr3_60098632_60098826 | 5.03 |
Sucnr1 |
succinate receptor 1 |
16827 |
0.18 |
chr9_78121577_78121736 | 5.02 |
Cilk1 |
ciliogenesis associated kinase 1 |
8341 |
0.13 |
chr14_25606696_25608421 | 5.02 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr1_105971579_105971738 | 5.02 |
Gm18801 |
predicted gene, 18801 |
15348 |
0.14 |
chr8_20817574_20818579 | 4.95 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr11_89807977_89808128 | 4.94 |
Ankfn1 |
ankyrin-repeat and fibronectin type III domain containing 1 |
30399 |
0.24 |
chr2_167586280_167586479 | 4.92 |
Gm11475 |
predicted gene 11475 |
5016 |
0.13 |
chr15_99651541_99652191 | 4.92 |
Racgap1 |
Rac GTPase-activating protein 1 |
210 |
0.88 |
chr15_59263522_59263680 | 4.91 |
Gm36617 |
predicted gene, 36617 |
11795 |
0.16 |
chr12_105759926_105760491 | 4.88 |
Ak7 |
adenylate kinase 7 |
14933 |
0.17 |
chr15_83530326_83530517 | 4.87 |
Bik |
BCL2-interacting killer |
3123 |
0.15 |
chr5_35973798_35974238 | 4.87 |
Afap1 |
actin filament associated protein 1 |
10170 |
0.25 |
chr8_95392769_95392956 | 4.86 |
Mmp15 |
matrix metallopeptidase 15 |
22991 |
0.11 |
chr9_107981626_107982218 | 4.85 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
1032 |
0.19 |
chr1_87891024_87891196 | 4.85 |
Gm38365 |
predicted gene, 38365 |
6430 |
0.13 |
chr2_32464470_32464843 | 4.85 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
13211 |
0.1 |
chr4_127263680_127264160 | 4.82 |
Smim12 |
small integral membrane protein 12 |
20136 |
0.12 |
chr11_53683293_53683444 | 4.82 |
Rad50 |
RAD50 double strand break repair protein |
3156 |
0.16 |
chr8_72268330_72268752 | 4.82 |
Ap1m1 |
adaptor-related protein complex AP-1, mu subunit 1 |
15606 |
0.1 |
chr11_117265661_117266789 | 4.82 |
Septin9 |
septin 9 |
21 |
0.97 |
chr10_59578107_59578404 | 4.80 |
Gm10322 |
predicted gene 10322 |
37808 |
0.15 |
chr11_34169627_34169839 | 4.80 |
Gm12121 |
predicted gene 12121 |
27906 |
0.16 |
chr17_46287753_46287927 | 4.80 |
Tjap1 |
tight junction associated protein 1 |
4814 |
0.11 |
chr2_91655955_91656364 | 4.78 |
Arhgap1 |
Rho GTPase activating protein 1 |
2951 |
0.15 |
chr2_69355529_69355681 | 4.77 |
Abcb11 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
12989 |
0.17 |
chr13_45391635_45391829 | 4.77 |
Mylip |
myosin regulatory light chain interacting protein |
805 |
0.69 |
chr15_83451661_83452019 | 4.76 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
12712 |
0.15 |
chrX_51204673_51205680 | 4.75 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr1_180830774_180830925 | 4.75 |
Gm24836 |
predicted gene, 24836 |
1920 |
0.19 |
chr8_121262895_121263071 | 4.74 |
5033426O07Rik |
RIKEN cDNA 5033426O07 gene |
59381 |
0.1 |
chr8_126497512_126498658 | 4.74 |
Gm6091 |
predicted pseudogene 6091 |
21673 |
0.18 |
chr13_52079928_52080168 | 4.73 |
Gm48190 |
predicted gene, 48190 |
16594 |
0.19 |
chr3_38275300_38275648 | 4.73 |
Gm2965 |
predicted gene 2965 |
52023 |
0.12 |
chr18_76929361_76929540 | 4.72 |
Ier3ip1 |
immediate early response 3 interacting protein 1 |
567 |
0.5 |
chr18_61768280_61768443 | 4.71 |
Afap1l1 |
actin filament associated protein 1-like 1 |
18250 |
0.14 |
chr2_146565808_146566015 | 4.71 |
4933406D12Rik |
RIKEN cDNA 4933406D12 gene |
22980 |
0.23 |
chr12_103863072_103863984 | 4.71 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr10_127632824_127633177 | 4.70 |
Gm48815 |
predicted gene, 48815 |
3387 |
0.11 |
chr15_51918163_51918500 | 4.70 |
Gm48923 |
predicted gene, 48923 |
21244 |
0.15 |
chr11_32946607_32946784 | 4.70 |
Gm12111 |
predicted gene 12111 |
20535 |
0.15 |
chr15_85735270_85736076 | 4.69 |
Ppara |
peroxisome proliferator activated receptor alpha |
34 |
0.97 |
chr2_158113431_158114232 | 4.69 |
Gm20412 |
predicted gene 20412 |
3323 |
0.2 |
chr15_83432795_83433001 | 4.69 |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
74 |
0.97 |
chr3_96564021_96564546 | 4.67 |
Gm15441 |
predicted gene 15441 |
2518 |
0.11 |
chr12_102453623_102453790 | 4.66 |
Gm30198 |
predicted gene, 30198 |
6378 |
0.17 |
chr8_72735103_72735443 | 4.66 |
Sin3b |
transcriptional regulator, SIN3B (yeast) |
5578 |
0.14 |
chr7_64058377_64058776 | 4.65 |
Gm20670 |
predicted gene 20670 |
974 |
0.52 |
chr5_144248241_144248469 | 4.65 |
2900089D17Rik |
RIKEN cDNA 2900089D17 gene |
1849 |
0.23 |
chr3_58234833_58235152 | 4.65 |
Gm26166 |
predicted gene, 26166 |
55365 |
0.11 |
chr15_97865247_97865455 | 4.65 |
Vdr |
vitamin D (1,25-dihydroxyvitamin D3) receptor |
5653 |
0.19 |
chr8_104846948_104847106 | 4.64 |
Ces2c |
carboxylesterase 2C |
41 |
0.9 |
chr3_88746948_88747134 | 4.63 |
Syt11 |
synaptotagmin XI |
5010 |
0.1 |
chr8_77492459_77492625 | 4.63 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
24514 |
0.14 |
chr2_167594436_167594909 | 4.63 |
Gm11475 |
predicted gene 11475 |
3277 |
0.16 |
chr11_94774856_94775172 | 4.63 |
Tmem92 |
transmembrane protein 92 |
7486 |
0.11 |
chr4_134734669_134734921 | 4.62 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
15312 |
0.18 |
chr13_23544226_23545176 | 4.61 |
H3c7 |
H3 clustered histone 7 |
649 |
0.31 |
chr6_52479372_52479523 | 4.60 |
1700094M24Rik |
RIKEN cDNA 1700094M24 gene |
13004 |
0.16 |
chr18_64850466_64850770 | 4.60 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
37087 |
0.12 |
chr19_47886722_47886925 | 4.60 |
Gsto2 |
glutathione S-transferase omega 2 |
16561 |
0.13 |
chr4_135277044_135277240 | 4.60 |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
4328 |
0.15 |
chr7_141463814_141464146 | 4.60 |
Cracr2b |
calcium release activated channel regulator 2B |
64 |
0.49 |
chr11_88999276_88999500 | 4.59 |
Trim25 |
tripartite motif-containing 25 |
12 |
0.96 |
chr8_88636074_88636252 | 4.57 |
Snx20 |
sorting nexin 20 |
35 |
0.97 |
chr4_128667339_128667490 | 4.57 |
Phc2 |
polyhomeotic 2 |
12676 |
0.17 |
chr9_53356660_53357108 | 4.56 |
Exph5 |
exophilin 5 |
15695 |
0.16 |
chr9_106908815_106908996 | 4.56 |
Dock3 |
dedicator of cyto-kinesis 3 |
120 |
0.94 |
chr9_67116044_67116314 | 4.55 |
Gm22145 |
predicted gene, 22145 |
11971 |
0.16 |
chr16_38362984_38363227 | 4.55 |
Popdc2 |
popeye domain containing 2 |
860 |
0.48 |
chr16_23218507_23218680 | 4.53 |
St6gal1 |
beta galactoside alpha 2,6 sialyltransferase 1 |
6147 |
0.11 |
chr9_21858188_21858381 | 4.50 |
Dock6 |
dedicator of cytokinesis 6 |
5649 |
0.11 |
chr18_61278473_61278624 | 4.49 |
Pde6a |
phosphodiesterase 6A, cGMP-specific, rod, alpha |
3525 |
0.21 |
chr11_54727422_54727590 | 4.48 |
Gm12227 |
predicted gene 12227 |
1171 |
0.41 |
chr1_138928720_138929159 | 4.48 |
Gm3933 |
predicted gene 3933 |
12896 |
0.11 |
chr4_44217169_44217327 | 4.47 |
Mir5106 |
microRNA 5106 |
4019 |
0.21 |
chr1_125526055_125526324 | 4.47 |
Slc35f5 |
solute carrier family 35, member F5 |
34406 |
0.2 |
chr10_61413342_61413765 | 4.46 |
Nodal |
nodal |
4419 |
0.13 |
chr7_45103031_45103408 | 4.46 |
Fcgrt |
Fc receptor, IgG, alpha chain transporter |
133 |
0.83 |
chr5_139732835_139733036 | 4.46 |
Micall2 |
MICAL-like 2 |
101 |
0.96 |
chr9_31602923_31603085 | 4.45 |
Gm18226 |
predicted gene, 18226 |
34758 |
0.13 |
chr15_85791584_85791735 | 4.45 |
Cdpf1 |
cysteine rich, DPF motif domain containing 1 |
19431 |
0.12 |
chr2_30658442_30659224 | 4.44 |
Gm14486 |
predicted gene 14486 |
11075 |
0.15 |
chr2_127314612_127314821 | 4.43 |
Dusp2 |
dual specificity phosphatase 2 |
21443 |
0.11 |
chr2_163574374_163574576 | 4.43 |
Hnf4a |
hepatic nuclear factor 4, alpha |
24392 |
0.11 |
chr13_40869116_40869281 | 4.42 |
Mir5124a |
microRNA 5124a |
3407 |
0.13 |
chr1_183041145_183041343 | 4.42 |
Gm24975 |
predicted gene, 24975 |
33362 |
0.16 |
chr2_120660523_120660854 | 4.42 |
Stard9 |
START domain containing 9 |
8272 |
0.15 |
chr17_47527579_47527833 | 4.41 |
Ccnd3 |
cyclin D3 |
22465 |
0.12 |
chr11_101885249_101885424 | 4.40 |
Gm11551 |
predicted gene 11551 |
901 |
0.48 |
chr5_135533501_135533652 | 4.39 |
Hip1 |
huntingtin interacting protein 1 |
11539 |
0.14 |
chr8_128112942_128113479 | 4.38 |
Mir21c |
microRNA 21c |
165015 |
0.04 |
chr17_12724917_12725682 | 4.37 |
Airn |
antisense Igf2r RNA |
16012 |
0.13 |
chr1_172501740_172502411 | 4.37 |
Tagln2 |
transgelin 2 |
823 |
0.43 |
chr8_84197696_84198961 | 4.37 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr11_54250694_54250851 | 4.37 |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
1105 |
0.38 |
chr11_44512552_44512737 | 4.37 |
Rnf145 |
ring finger protein 145 |
6320 |
0.18 |
chr7_34290925_34291076 | 4.37 |
4931406P16Rik |
RIKEN cDNA 4931406P16 gene |
5401 |
0.13 |
chr9_64055309_64055460 | 4.36 |
Gm25606 |
predicted gene, 25606 |
6888 |
0.13 |
chr3_79181270_79181482 | 4.36 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
36 |
0.98 |
chr15_74921432_74921762 | 4.35 |
Gm6610 |
predicted gene 6610 |
2847 |
0.13 |
chr11_116195314_116195641 | 4.34 |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
3252 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.0 | 9.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.5 | 12.7 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
2.5 | 7.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
2.3 | 7.0 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
2.2 | 6.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.1 | 10.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.1 | 2.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.0 | 6.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
2.0 | 6.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.0 | 5.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.9 | 1.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.9 | 5.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.9 | 7.4 | GO:0007296 | vitellogenesis(GO:0007296) |
1.8 | 5.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.8 | 1.8 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
1.8 | 5.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.7 | 1.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.7 | 3.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.7 | 5.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.7 | 1.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
1.6 | 8.1 | GO:0070836 | caveola assembly(GO:0070836) |
1.6 | 6.4 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.6 | 6.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.6 | 7.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.5 | 7.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.5 | 10.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.4 | 4.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.4 | 5.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.4 | 4.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.4 | 5.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.4 | 4.1 | GO:0000087 | mitotic M phase(GO:0000087) |
1.4 | 6.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.4 | 4.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.4 | 4.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.3 | 4.0 | GO:1902075 | cellular response to salt(GO:1902075) |
1.3 | 4.0 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.3 | 4.0 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.3 | 5.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.3 | 3.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.3 | 2.6 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
1.3 | 3.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.3 | 5.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 1.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
1.2 | 3.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.2 | 3.7 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.2 | 6.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.2 | 3.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 5.9 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.2 | 3.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.2 | 3.5 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.2 | 3.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.2 | 1.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.2 | 3.5 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.2 | 5.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.1 | 3.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.1 | 3.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 3.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.1 | 3.4 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
1.1 | 9.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.1 | 3.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 4.5 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.1 | 4.5 | GO:0002159 | desmosome assembly(GO:0002159) |
1.1 | 4.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.1 | 5.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
1.1 | 3.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.1 | 4.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.1 | 3.2 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.1 | 2.1 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
1.1 | 1.1 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
1.1 | 1.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.0 | 5.1 | GO:0015825 | L-serine transport(GO:0015825) |
1.0 | 3.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
1.0 | 1.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
1.0 | 2.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.0 | 15.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.0 | 5.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.0 | 20.8 | GO:0001945 | lymph vessel development(GO:0001945) |
1.0 | 6.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.0 | 4.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.0 | 4.9 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.0 | 3.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.0 | 2.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.0 | 2.9 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
1.0 | 2.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.0 | 1.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.9 | 1.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.9 | 2.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.9 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.9 | 0.9 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.9 | 3.6 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.9 | 4.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 0.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.9 | 5.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.9 | 2.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.9 | 3.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.9 | 2.7 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.9 | 2.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.9 | 1.8 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.9 | 5.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.9 | 3.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 19.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.9 | 3.5 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.9 | 2.6 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.9 | 2.6 | GO:0036166 | phenotypic switching(GO:0036166) |
0.9 | 3.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.9 | 2.6 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 3.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.8 | 0.8 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.8 | 7.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 2.5 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.8 | 2.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.8 | 3.3 | GO:0009597 | detection of virus(GO:0009597) |
0.8 | 1.6 | GO:0003186 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
0.8 | 4.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 2.4 | GO:0008050 | female courtship behavior(GO:0008050) |
0.8 | 0.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.8 | 2.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.8 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.8 | 1.6 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.8 | 3.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.8 | 0.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.8 | 3.2 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.8 | 3.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.8 | 2.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 1.6 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.8 | 1.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.8 | 2.3 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 2.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.8 | 9.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.8 | 0.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 3.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.8 | 3.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.8 | 2.3 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.8 | 6.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 3.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.8 | 0.8 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 3.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 1.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.7 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.7 | 5.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.7 | 2.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.7 | 2.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.7 | 2.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.7 | 2.9 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.7 | 3.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 2.9 | GO:0045404 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.7 | 1.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 5.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.7 | 1.4 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.7 | 1.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.7 | 0.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 2.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.7 | 2.2 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.7 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.7 | 2.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 0.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.7 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 1.4 | GO:0050904 | diapedesis(GO:0050904) |
0.7 | 2.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 3.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.7 | 3.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.7 | 2.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 2.1 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.7 | 0.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.7 | 2.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.7 | 2.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.7 | 1.4 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.7 | 2.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.7 | 0.7 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.7 | 1.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.7 | 4.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.7 | 2.1 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.7 | 1.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.7 | 2.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.7 | 2.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 2.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 1.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.7 | 2.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.7 | 2.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 3.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 3.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 6.7 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.7 | 3.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.7 | 11.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.7 | 0.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.7 | 9.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.7 | 2.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.7 | 3.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 4.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 2.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.7 | 2.7 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.7 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 2.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.7 | 5.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 1.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 3.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 0.6 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) regulation of eosinophil migration(GO:2000416) |
0.6 | 1.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.6 | 1.9 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.6 | 1.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.6 | 6.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.6 | 7.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.6 | 1.9 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.6 | 3.8 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.6 | 2.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.6 | 1.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.6 | 1.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.6 | 4.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 1.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.6 | 3.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.6 | 1.8 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 1.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.6 | 3.7 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.6 | 4.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 2.4 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.6 | 6.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.6 | 4.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.6 | 0.6 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.6 | 1.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.6 | 3.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 2.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 1.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 4.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 1.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.6 | 3.5 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.6 | 1.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.6 | 1.2 | GO:0000050 | urea cycle(GO:0000050) |
0.6 | 3.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 3.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 4.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.6 | 1.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.6 | 1.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.6 | 10.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.6 | 0.6 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.6 | 1.7 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.6 | 0.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 18.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.6 | 0.6 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.6 | 1.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.6 | 0.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 2.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.6 | 1.7 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.6 | 1.7 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.6 | 1.7 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.6 | 2.8 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.6 | 1.7 | GO:0001555 | oocyte growth(GO:0001555) |
0.6 | 1.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.6 | 1.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 3.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.6 | 0.6 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.6 | 1.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.6 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.5 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 1.6 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 1.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.5 | 1.1 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.5 | 1.6 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 5.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.5 | 3.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 3.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 2.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 1.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 3.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 1.6 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.5 | 2.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.5 | 4.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 1.1 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 2.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 1.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.5 | 2.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.5 | 3.7 | GO:0035733 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.5 | 3.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.5 | 2.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 1.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 2.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 2.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 2.6 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 0.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.5 | 1.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 1.6 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 0.5 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.5 | 1.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 3.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.5 | 1.0 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.5 | 0.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.5 | 1.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 3.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.5 | 1.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.5 | 0.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.5 | 2.0 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.5 | 0.5 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.5 | 1.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 3.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 1.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.5 | 2.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.5 | 1.5 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.5 | 1.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 1.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.5 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 1.0 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.5 | 3.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 3.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 6.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.5 | 3.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.5 | 2.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 1.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.5 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.5 | 2.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 1.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.5 | 2.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 1.9 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.5 | 2.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.5 | 3.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 1.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 11.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 1.9 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.5 | 0.5 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.5 | 1.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.5 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.5 | 0.5 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.5 | 1.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 1.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 1.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 1.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.5 | 1.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.5 | 4.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 1.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.5 | 0.5 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 0.5 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.5 | 2.8 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) |
0.5 | 1.4 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 1.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 0.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.5 | 1.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 2.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 0.5 | GO:0003383 | apical constriction(GO:0003383) |
0.5 | 1.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 1.4 | GO:0032345 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.5 | 2.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 1.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 1.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.5 | 1.4 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 2.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.5 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
0.5 | 0.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.5 | 5.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 1.4 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.5 | 1.8 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.5 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 0.5 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.5 | 1.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 1.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 0.9 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.5 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 0.9 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 1.8 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 5.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 0.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 0.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 1.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 1.8 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.4 | 1.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.4 | 4.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 3.1 | GO:0051044 | regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 3.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 0.4 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 3.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 4.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 1.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.4 | 1.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 0.9 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 2.2 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.4 | 1.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 2.6 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 3.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.4 | 0.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 0.4 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.4 | 0.9 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.4 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 0.9 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.4 | 3.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.4 | 1.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.4 | 1.7 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.4 | 1.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.4 | 1.3 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 1.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 4.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.4 | 9.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.4 | 0.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.4 | 1.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 2.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.4 | 1.7 | GO:0009414 | response to water deprivation(GO:0009414) |
0.4 | 8.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 1.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 2.5 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 1.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.4 | 5.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 1.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 0.4 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.4 | 0.4 | GO:0032349 | regulation of glucocorticoid biosynthetic process(GO:0031946) positive regulation of aldosterone metabolic process(GO:0032346) regulation of aldosterone biosynthetic process(GO:0032347) positive regulation of aldosterone biosynthetic process(GO:0032349) regulation of cortisol biosynthetic process(GO:2000064) |
0.4 | 0.4 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.4 | 1.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 0.4 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.4 | 7.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.4 | 1.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 2.9 | GO:0030238 | male sex determination(GO:0030238) |
0.4 | 0.8 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.4 | 0.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.4 | 1.2 | GO:0010878 | cholesterol storage(GO:0010878) |
0.4 | 1.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.4 | 1.6 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 1.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 0.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.4 | 1.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 0.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.4 | 0.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.4 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 4.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 0.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.4 | 0.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 0.8 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 0.4 | GO:0046755 | viral budding via host ESCRT complex(GO:0039702) multi-organism membrane organization(GO:0044803) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.4 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.4 | 0.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 0.8 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 2.8 | GO:0030033 | microvillus assembly(GO:0030033) |
0.4 | 1.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 2.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 1.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.4 | 1.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 4.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.4 | 5.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.4 | 0.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 1.9 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.4 | 2.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.4 | 1.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 7.0 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.4 | 1.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 5.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.4 | 0.8 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.4 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 2.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 0.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.4 | 0.4 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.4 | 3.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 0.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 3.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 0.4 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.4 | 3.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.4 | 3.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.4 | 1.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 3.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.4 | 0.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 3.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 3.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.4 | 1.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 2.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.4 | 1.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 0.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.4 | 0.8 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.4 | 1.9 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.4 | 1.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.4 | 3.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.4 | 1.5 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.4 | 1.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 1.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.4 | 1.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 1.5 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.4 | 1.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.4 | 1.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 2.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.4 | 2.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 2.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.4 | 0.4 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.4 | 1.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 0.4 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.4 | 1.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 0.7 | GO:0060842 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.4 | 3.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.4 | 1.4 | GO:0015809 | arginine transport(GO:0015809) |
0.4 | 3.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.4 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 8.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 1.8 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.4 | 1.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 0.7 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
0.4 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.4 | 5.6 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.4 | 2.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.4 | 0.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 2.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.3 | 0.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 2.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 1.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 1.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 1.0 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.3 | 1.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.3 | 0.3 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.3 | 4.4 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.3 | 0.7 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.3 | 1.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.3 | 0.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.3 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.3 | 1.0 | GO:0009189 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 1.0 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.7 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.3 | 4.7 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.3 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 0.7 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.3 | 0.3 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.3 | 1.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 0.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.3 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 1.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 0.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 0.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 2.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 1.6 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.3 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.6 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.3 | 0.6 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.3 | 1.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.3 | 1.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 3.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.3 | 0.6 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 2.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.3 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 0.9 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 0.6 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.3 | 1.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 0.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.3 | 2.2 | GO:0035878 | nail development(GO:0035878) |
0.3 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 1.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 3.4 | GO:0043486 | histone exchange(GO:0043486) |
0.3 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.9 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 3.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.3 | 0.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 0.3 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.3 | 0.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 0.9 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.3 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 1.8 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 4.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 4.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.3 | 0.3 | GO:0042737 | drug catabolic process(GO:0042737) |
0.3 | 3.3 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.3 | 1.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 0.6 | GO:0097242 | beta-amyloid clearance(GO:0097242) regulation of beta-amyloid clearance(GO:1900221) |
0.3 | 2.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 2.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 0.3 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.3 | 1.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 2.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 0.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.3 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.3 | 3.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 1.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.3 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 1.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 2.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 1.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 3.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 0.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.3 | 2.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.6 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 0.3 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.3 | 1.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 0.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 0.9 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 0.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.3 | 1.4 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 2.9 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.3 | 0.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.3 | 0.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.6 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.3 | 1.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 0.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 1.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.3 | 0.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.3 | 3.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 2.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 1.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 1.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 1.4 | GO:0001840 | neural plate development(GO:0001840) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 0.3 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.3 | 1.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 3.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 1.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 1.1 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.3 | 0.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.5 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.3 | 1.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.3 | 0.8 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.3 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 1.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 0.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 0.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 1.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 0.5 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.3 | 1.4 | GO:0007379 | segment specification(GO:0007379) |
0.3 | 1.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.3 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 0.3 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.3 | 0.8 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 1.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 1.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 1.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.3 | 0.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 0.3 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.3 | 0.8 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 2.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 0.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.3 | 1.6 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 1.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 0.8 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 0.8 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.3 | 1.3 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 2.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.8 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 7.0 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.3 | 1.3 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 2.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 | 0.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 7.4 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.3 | 2.0 | GO:0044773 | mitotic DNA damage checkpoint(GO:0044773) |
0.3 | 3.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 1.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 0.8 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.3 | 2.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.5 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 1.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 1.0 | GO:0044794 | positive regulation by host of viral process(GO:0044794) positive regulation by host of viral genome replication(GO:0044829) |
0.2 | 1.5 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.2 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.2 | 0.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 3.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 3.0 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 1.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 1.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 1.0 | GO:1902884 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.2 | 2.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.5 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.2 | 5.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.7 | GO:0001832 | blastocyst growth(GO:0001832) |
0.2 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 4.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.2 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.2 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 1.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.2 | 0.5 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.2 | GO:0045073 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.2 | 1.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 1.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 0.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 0.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 1.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.2 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 1.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 1.9 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.2 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.2 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 0.5 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 2.3 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.2 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.2 | 0.9 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.2 | 1.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 0.9 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 2.3 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 2.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 2.5 | GO:0034505 | tooth mineralization(GO:0034505) |
0.2 | 0.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 2.3 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.9 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 2.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.9 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.2 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 1.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 1.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 2.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 2.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 1.3 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 1.8 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 2.0 | GO:0098751 | bone cell development(GO:0098751) |
0.2 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 4.4 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.2 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 2.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.2 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.4 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 3.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 1.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 0.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 0.4 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 2.5 | GO:0070266 | necroptotic process(GO:0070266) |
0.2 | 4.7 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.2 | 6.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 1.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 3.6 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.6 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.2 | 3.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.4 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 1.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 2.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.2 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.2 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 2.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 1.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.2 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 1.8 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.2 | 0.6 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 2.0 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 1.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 2.4 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.2 | 0.4 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.4 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.2 | 1.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 2.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 3.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 1.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 1.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 1.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 2.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 1.5 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.2 | 2.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 1.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 1.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 2.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.2 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.2 | 2.3 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 6.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.2 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 1.1 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 3.4 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.2 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 1.1 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.2 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 0.9 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.6 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) specification of axis polarity(GO:0065001) |
0.2 | 1.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.9 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 0.4 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 4.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 2.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.4 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.2 | 0.4 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.9 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.2 | 0.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 0.4 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 1.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.5 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.2 | 0.2 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 0.9 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 2.9 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.2 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.2 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.2 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.5 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.2 | 0.5 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.2 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 1.6 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 0.2 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.2 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.5 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 0.2 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.2 | 1.8 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.2 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.9 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.2 | GO:0097709 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.2 | 0.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.2 | 0.3 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.2 | 0.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 0.7 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 0.2 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.2 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.2 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.8 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 2.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 1.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 0.8 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 2.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.2 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 1.0 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.2 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.2 | 0.2 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.2 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 0.2 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.6 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.2 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.2 | GO:1901563 | response to camptothecin(GO:1901563) |
0.2 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 1.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 1.3 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.2 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.2 | 0.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.2 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.2 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) |
0.2 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 0.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 1.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.2 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 1.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.5 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.2 | 0.9 | GO:1901070 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) guanosine-containing compound biosynthetic process(GO:1901070) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.2 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 4.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 0.2 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.2 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.3 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 0.6 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 1.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 3.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.7 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.4 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 1.0 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 1.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.7 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.6 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.4 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 1.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.1 | GO:0072071 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.4 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 2.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 2.1 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.1 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.7 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 1.1 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 2.4 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.1 | GO:0021571 | rhombomere 4 development(GO:0021570) rhombomere 5 development(GO:0021571) |
0.1 | 0.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 3.2 | GO:0003281 | ventricular septum development(GO:0003281) |
0.1 | 0.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 1.0 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.5 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.8 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 1.2 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.1 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:2000677 | regulation of transcription regulatory region DNA binding(GO:2000677) |
0.1 | 1.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.9 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.9 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 1.5 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 7.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 3.3 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 1.7 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 2.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 1.0 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 0.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 3.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.8 | GO:0071385 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 0.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.8 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.2 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 2.9 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 0.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 1.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.2 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 2.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.4 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 1.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 1.2 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 1.5 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 2.0 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.7 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.5 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.9 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.5 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.1 | 0.7 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.1 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.1 | 0.3 | GO:0015908 | fatty acid transport(GO:0015908) |
0.1 | 0.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 1.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 1.9 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.3 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.1 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.7 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.1 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 1.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.3 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 0.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.1 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.8 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.9 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:0032438 | melanosome organization(GO:0032438) |
0.1 | 0.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.5 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.1 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 1.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 2.0 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.4 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 3.2 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.1 | 0.7 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 1.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 0.1 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.2 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.8 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.6 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 2.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 1.1 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.4 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.6 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.4 | GO:0001759 | organ induction(GO:0001759) |
0.1 | 0.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.8 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0072526 | quinolinate metabolic process(GO:0046874) pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.3 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 1.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.2 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 1.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.2 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.1 | 0.2 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.1 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:0090151 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.1 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 1.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.2 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 1.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.0 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.0 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.0 | 0.0 | GO:0032374 | regulation of sterol transport(GO:0032371) regulation of cholesterol transport(GO:0032374) |
0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 1.2 | GO:0007596 | blood coagulation(GO:0007596) hemostasis(GO:0007599) coagulation(GO:0050817) |
0.0 | 1.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 1.3 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.3 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.3 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.0 | 0.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.6 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.5 | GO:0001890 | placenta development(GO:0001890) |
0.0 | 3.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 2.1 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 1.0 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.2 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.0 | 1.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.3 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.2 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.0 | 1.8 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.0 | GO:0042181 | ketone biosynthetic process(GO:0042181) |
0.0 | 0.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0060061 | Spemann organizer formation(GO:0060061) limb bud formation(GO:0060174) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.0 | 0.2 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.0 | 0.2 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.2 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.0 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.2 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.1 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.0 | 0.2 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 1.0 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 4.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
2.2 | 6.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.0 | 8.1 | GO:0030689 | Noc complex(GO:0030689) |
1.7 | 5.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.5 | 10.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.4 | 5.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.4 | 13.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.3 | 6.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.2 | 3.7 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 4.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.2 | 4.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.1 | 8.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.1 | 5.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 3.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.1 | 6.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.0 | 7.0 | GO:0030056 | hemidesmosome(GO:0030056) |
1.0 | 3.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.9 | 7.6 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 2.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.9 | 3.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.9 | 4.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 2.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 4.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 13.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.8 | 3.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.7 | 3.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.7 | 1.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 4.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 2.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.7 | 2.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.7 | 42.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.7 | 1.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.7 | 1.4 | GO:0090543 | Flemming body(GO:0090543) |
0.7 | 3.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.7 | 8.1 | GO:0002102 | podosome(GO:0002102) |
0.6 | 1.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 10.2 | GO:0031430 | M band(GO:0031430) |
0.6 | 2.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 3.6 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 4.6 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 2.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 1.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 2.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 1.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 2.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 9.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.5 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.5 | 2.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 3.1 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.5 | 2.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 2.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 11.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 2.0 | GO:0000938 | GARP complex(GO:0000938) |
0.5 | 1.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.5 | 7.2 | GO:0000786 | nucleosome(GO:0000786) |
0.5 | 2.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.5 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.5 | 2.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 1.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 1.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 2.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 1.8 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 2.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.5 | 1.8 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 4.1 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 3.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 5.4 | GO:0043034 | costamere(GO:0043034) |
0.4 | 0.9 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 5.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 1.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.4 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 1.3 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 3.8 | GO:0042641 | actomyosin(GO:0042641) |
0.4 | 3.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 1.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 4.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 1.3 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 3.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 2.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 2.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 1.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 1.6 | GO:0035363 | histone locus body(GO:0035363) |
0.4 | 2.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 3.2 | GO:0042627 | chylomicron(GO:0042627) |
0.4 | 1.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 2.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 2.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 26.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 1.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 4.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 2.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 3.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.4 | 1.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 5.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.4 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 5.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 3.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 4.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 3.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 1.1 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 6.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.4 | 1.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.4 | 3.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 14.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 2.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 0.7 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 2.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 1.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 2.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 2.0 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 6.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 1.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 13.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 2.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 1.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 6.3 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.3 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 0.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.3 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 0.9 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 1.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 17.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 3.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 2.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 0.6 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 2.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 5.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 4.4 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 1.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 10.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.3 | 1.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 0.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 3.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 0.8 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 2.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 3.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 5.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 1.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 18.5 | GO:0005901 | caveola(GO:0005901) |
0.3 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 1.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 1.3 | GO:0005818 | aster(GO:0005818) |
0.3 | 2.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 0.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.3 | 2.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 1.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 1.0 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 21.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 2.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 2.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 6.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 8.9 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 2.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.8 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.2 | 0.5 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 13.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.6 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 6.1 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 18.2 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 2.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 1.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 1.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 5.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 0.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 6.9 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.6 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 2.7 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 4.9 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 1.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 0.4 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 2.5 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 4.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 0.7 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.2 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 1.7 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.2 | 0.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 9.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 1.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 5.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 2.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.5 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 5.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 0.7 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 1.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 1.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 36.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 2.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 3.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 15.8 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 0.5 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 8.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 3.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.2 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 2.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0031672 | A band(GO:0031672) |
0.1 | 9.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.9 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 6.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 9.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 1.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 9.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 1.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 1.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 4.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 6.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) phagolysosome(GO:0032010) |
0.1 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 2.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 2.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 11.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.4 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 1.2 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 1.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 3.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 8.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 3.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 9.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 6.0 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 2.6 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 2.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.4 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.4 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 1.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.2 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.1 | 1.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.5 | GO:0045259 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.4 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 8.7 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 10.0 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 8.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 16.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 5.7 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.1 | 3.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.9 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.7 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.3 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 3.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.8 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.1 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 51.8 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 51.3 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.2 | GO:0044440 | endosomal part(GO:0044440) |
0.1 | 0.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 1.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 3.1 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 3.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.8 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 4.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.6 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 4.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 42.1 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 24.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.6 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 7.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 1.9 | GO:0005740 | mitochondrial envelope(GO:0005740) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.7 | 10.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.5 | 7.6 | GO:0035877 | death effector domain binding(GO:0035877) |
2.1 | 6.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.1 | 6.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
2.0 | 8.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.0 | 5.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.9 | 5.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 12.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.7 | 8.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.7 | 5.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.7 | 6.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.7 | 5.1 | GO:0030172 | troponin C binding(GO:0030172) |
1.6 | 14.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.5 | 8.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.5 | 10.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.4 | 4.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.3 | 3.9 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.3 | 1.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.3 | 3.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.3 | 3.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.2 | 4.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 1.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
1.2 | 6.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.1 | 13.7 | GO:0044548 | S100 protein binding(GO:0044548) |
1.1 | 3.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.0 | 9.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.0 | 2.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 6.8 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 1.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.0 | 1.9 | GO:0030911 | TPR domain binding(GO:0030911) |
1.0 | 1.9 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.9 | 3.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 3.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.9 | 3.6 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 6.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.9 | 4.3 | GO:0070061 | fructose binding(GO:0070061) |
0.9 | 3.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 5.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 8.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.8 | 5.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.8 | 2.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 4.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.8 | 4.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.8 | 2.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 11.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 4.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.8 | 0.8 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.8 | 3.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.8 | 6.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.8 | 3.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 2.3 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.8 | 4.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.8 | 3.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.7 | 11.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 1.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 2.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.7 | 5.8 | GO:0008430 | selenium binding(GO:0008430) |
0.7 | 7.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 2.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 2.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 1.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.7 | 1.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 2.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.7 | 8.9 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.7 | 2.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 2.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.7 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 2.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.7 | 2.7 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.7 | 13.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 2.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.7 | 2.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.7 | 2.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 7.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 2.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.6 | 7.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.6 | 1.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 1.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.6 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 1.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 1.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.6 | 17.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.6 | 2.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.6 | 3.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.6 | 1.8 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.6 | 3.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 2.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 1.8 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 2.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.6 | 5.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 3.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.6 | 13.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 1.8 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 6.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 7.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.6 | 4.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 6.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 1.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.6 | 1.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.6 | 3.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 0.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.6 | 1.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 6.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 1.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 13.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 1.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.6 | 2.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.6 | 2.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 1.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.6 | 1.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 3.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 5.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.6 | 3.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 3.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.6 | 2.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 1.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 4.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 0.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.5 | 2.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 2.7 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 4.8 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.5 | 2.7 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.5 | 2.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 0.5 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.5 | 3.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 3.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 1.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.5 | 5.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.5 | 1.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 2.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 2.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 1.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 0.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.5 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 2.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 1.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.5 | 2.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 2.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 4.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.5 | 3.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 1.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 1.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 3.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 6.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 12.7 | GO:0043236 | laminin binding(GO:0043236) |
0.5 | 0.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.5 | 2.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.5 | 2.3 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 0.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 7.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 3.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 7.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.5 | 0.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.5 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.5 | 2.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 12.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 2.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 1.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.5 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 4.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 0.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 0.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 1.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 1.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 1.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.4 | 1.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.4 | 2.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 6.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.4 | 1.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 0.4 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.4 | 1.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 1.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 0.4 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.4 | 8.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 1.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.4 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 8.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.4 | 1.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 2.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 2.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 1.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 5.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 0.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 2.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.4 | 1.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 1.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 2.0 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 3.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 1.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 3.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 1.9 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 10.9 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 12.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 1.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 1.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.4 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 1.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 1.8 | GO:0018642 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.4 | 2.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.4 | 1.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 11.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 2.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 1.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 38.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 1.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.3 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.3 | 0.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 24.0 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 3.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 1.0 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 5.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 2.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 9.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 10.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 2.3 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 1.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 1.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 1.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 2.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 3.9 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 4.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 4.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 5.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 4.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 2.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 2.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.3 | 3.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 2.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 6.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 3.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 2.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 4.0 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 0.9 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.3 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 2.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 2.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 2.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 1.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 3.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 0.9 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 0.8 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 1.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.3 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 2.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 4.1 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 2.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 2.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 6.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 1.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 4.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 4.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 1.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 8.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.3 | 1.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.3 | 0.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 2.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 0.5 | GO:1990188 | euchromatin binding(GO:1990188) |
0.3 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.9 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 2.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 1.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 2.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 27.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 4.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 1.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.2 | 0.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 0.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 1.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 3.2 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 3.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 3.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 1.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 6.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 2.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 1.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 3.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.5 | GO:0051379 | epinephrine binding(GO:0051379) |
0.2 | 1.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.9 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 5.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.2 | 1.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 7.2 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.2 | 0.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 3.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.6 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 0.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.7 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 3.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 2.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 5.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.1 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 16.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.2 | 11.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.6 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 1.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.9 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.2 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.2 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 2.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 2.1 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 4.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 1.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 2.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 1.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 7.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 0.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 9.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 1.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.6 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 1.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 14.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 1.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 1.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 3.7 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 2.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 1.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 2.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 2.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 2.2 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 0.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 1.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 1.1 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.2 | 4.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 1.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.4 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 0.7 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 7.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 1.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.2 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 4.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 2.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 26.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 1.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.3 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 4.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.8 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 4.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 3.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 3.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 10.8 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.2 | 1.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 7.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.2 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 9.7 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 2.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 2.4 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 1.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 4.5 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 4.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 2.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 7.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 3.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 4.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 18.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.5 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 3.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 3.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 1.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 1.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.2 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 1.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 5.7 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 2.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 2.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 4.4 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 2.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 2.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.9 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.7 | GO:0019176 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 1.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 2.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.5 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.7 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.2 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 2.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 1.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.1 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 0.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 5.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 0.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 4.7 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 2.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 3.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.1 | 0.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 1.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 1.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 22.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 5.9 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 1.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 2.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 2.2 | GO:0008134 | transcription factor binding(GO:0008134) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.3 | GO:0005518 | collagen binding(GO:0005518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 8.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.8 | 20.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 34.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.8 | 6.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 7.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 6.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 13.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.7 | 29.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 21.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.6 | 15.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.6 | 1.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 10.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 24.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 16.1 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 12.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 3.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 2.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 10.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 14.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 6.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 13.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 9.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 0.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.5 | 9.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 8.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 4.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 4.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 18.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 1.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 5.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 11.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.4 | 1.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 4.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 7.3 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 12.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 1.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 10.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 1.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 2.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 14.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 1.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 5.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 19.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 1.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 1.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 5.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 10.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 3.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 0.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 11.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 0.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 2.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 2.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 4.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 3.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 3.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 2.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 3.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 1.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 8.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 1.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 3.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.3 | PID ATM PATHWAY | ATM pathway |
0.2 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 0.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 5.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 6.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 5.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 6.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 1.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 3.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 2.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 2.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 2.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 2.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 3.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 5.9 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 3.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 2.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 1.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 4.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 3.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 20.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 8.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 3.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 4.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.7 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 16.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 4.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.1 | PID FOXO PATHWAY | FoxO family signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
1.6 | 17.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.3 | 6.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.9 | 10.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.9 | 11.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.9 | 7.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.9 | 11.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.9 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 18.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.8 | 19.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 16.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 13.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 0.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.7 | 17.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.7 | 7.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.7 | 0.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.6 | 2.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.6 | 0.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 8.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.6 | 5.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 6.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 13.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 17.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 5.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 7.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 10.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.5 | 5.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 4.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 2.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 0.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 6.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 10.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.5 | 6.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.5 | 12.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 5.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 3.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 3.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 5.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 4.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 4.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 4.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 0.9 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.4 | 5.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 18.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 3.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.4 | 3.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 5.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 4.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 6.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 37.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 2.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 4.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 3.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 4.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 10.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 5.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.4 | 4.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 3.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 2.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 3.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 2.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 2.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 8.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 3.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 6.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 8.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.4 | 2.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 3.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 4.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 3.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.3 | 8.8 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 3.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 5.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 9.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 4.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 1.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 2.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 8.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 3.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 3.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 1.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 2.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 6.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 1.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 4.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 4.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 26.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.3 | 1.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 3.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 0.3 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.3 | 4.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 1.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 3.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 3.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 3.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 3.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 5.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 3.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 1.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 5.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 3.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 0.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 2.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 6.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 3.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 0.4 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 13.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 1.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 2.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 1.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 3.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 7.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 5.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 0.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 1.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 6.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 0.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 2.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 2.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 1.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 3.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 1.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 3.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 0.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 2.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 6.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 1.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 3.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 7.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 4.3 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 7.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 6.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 2.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 2.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 4.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.1 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.1 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 2.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 17.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.1 | 0.7 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 1.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 2.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 4.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 1.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 1.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |